Clinical Benefits of Olaparib in Mexican Ovarian Cancer Patients With Founder Mutation BRCA1-Del ex9-12.
Gallardo-Rincón D, Montes-Servín E, Alamilla-García G, Montes-Servín E, Bahena-González A, Cetina-Pérez L, Morales Vásquez F, Cano-Blanco C, Coronel-Martínez J, González-Ibarra E, Espinosa-Romero R, María Alvarez-Gómez R, Pedroza-Torres A, Castro-Eguiluz D.
Gallardo-Rincón D, et al. Among authors: morales vasquez f.
Front Genet. 2022 Jun 6;13:863956. doi: 10.3389/fgene.2022.863956. eCollection 2022.
Front Genet. 2022.
PMID: 35734436
Free PMC article.